抑制MAGL可以通过调节Nrf2信号调节来改善葡萄糖皮质激素诱导的骨损失
Chongjun Huang1, Xiaohui Wang2, Shijia Liu1
1Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, China.
Free radical biology & medicine
|November 16, 2025
概括
葡萄糖皮质类药物通过增加骨质细胞活性导致骨质损失. 这项研究表明,通过激活Keap1/Nrf2抗氧化途径,抑制单糖醇脂酶 (MAGL) 降低了这种效果,为葡萄糖皮质醇诱导的骨质疏松症 (GIO) 提供了潜在的治疗方法.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质醇 (GCs) 对于治疗炎症性疾病至关重要,但会导致严重的骨质损失,导致葡萄糖皮质醇诱导的骨质疏松症 (GIO).
- 骨质细胞生成,即骨再吸收细胞的形成,是GIO的一个关键因素,但GC调节的确切机制仍然不清楚.
- 单糖醇脂酶 (MAGL) 调节内分泌大麻素信号传递和氧化应激,这与骨质细胞分化有关.
研究的目的:
- 调查MAGL在GC介导的骨质细胞分化和GIO中的作用.
- 探索涉及Keap1/Nrf2抗氧化途径的潜在分子机制.
主要方法:
- 在体外研究使用细胞培养来评估骨质细胞分化和骨再吸收标志物.
- 在动物模型中进行体内实验,以评估骨损失.
- 马格尔的淘汰和抑制实验.
- 对Keap1/Nrf2信号通路激活的分析.
主要成果:
- GC治疗显著增加了骨质细胞分化和MAGL表达.
- 马格尔 knockdown 抑制了GC诱导的骨质结晶生成和骨质再吸收.
- 抑制MAGL激活了Keap1/Nrf2抗氧化途径,减少了氧化应激.
- 在体内,MAGL抑制有效地减弱了GC诱导的骨损失.
结论:
- 马格尔在GC诱导的骨质细胞分化和骨损失中起着至关重要的作用.
- 通过激活Keap1/Nrf2抗氧化途径,MAGL抑制可以减轻GIO.
- 马格尔代表了一个有前途的治疗目标,用于预防和治疗GIO.
相关概念视频
01:16TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
02:26NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K